First-in-human evaluation of a novel ultrathin sirolimus-eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trial.
Gao RL, Xu B, Sun Z, Guan C, Song L, Gao L, Li C, Cui J, Zhang Y, Dou K, Chen J, Mu C, Liu H, Li A, Li Z, Xie L, Yang Y, Qiao S, Wu Y, Stone GW.
Gao RL, et al. Among authors: li c, li z, li a.
EuroIntervention. 2023 Jun 19;19(3):222-231. doi: 10.4244/EIJ-D-22-00919.
EuroIntervention. 2023.
PMID: 37038724
Free PMC article.
Clinical Trial.